The adoption of interventions in the NF-κB signaling pathway to further modulate autophagy mechanisms can not only bring new ideas for the diagnosis of IBD but also facilitate the development of new therapeutic opportunities for IBD. This evidence concerns the gene NFKB1 and inflammatory bowel disease.